Research output per year
Research output per year
Personal profile
Research interests
Our group is interested in developing predictive and prognostic biomarkers in patients with non-small cell lung cancer(NSCLC). We have identified a 64 gene signature that accurately predicts the outcomes of patients with resected early stage NSCLC. We are in the process of developing a q RT PCR assay that could be performed in formalin fixed paraffin embedded tissues. We are also pursuing genomic predictors of recurrence in the brain as brain metastases from NSCLC is a major cause of morbidity and mortality. We are actively studying distinctive molecular changes associated with lung cancer in lifelong never smokers. Finally, our group is interested in exploring novel agents in the treatment of advanced NSCLC.
Clinical interests
Esophageal, thoracic and lung cancer
Fingerprint
Dive into the research topics where Ramaswamy Govindan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Clinician Perspectives on Barriers and Enablers to Implementing an Inpatient Oncology Early Warning System: A Mixed-Methods Study
Lyons, P. G., Chen, V., Sekhar, T. C., McEvoy, C. A., Kollef, M. H., Govindan, R., Westervelt, P., Vranas, K. C., Maddox, T. M., Geng, E. H., Payne, P. R. O. & Politi, M. C., Jan 1 2023, In: JCO Clinical Cancer Informatics. 7, p. e2200104Research output: Contribution to journal › Article › peer-review
-
Clonal Hematopoiesis and Risk of Incident Lung Cancer
Tian, R., Wiley, B., Liu, J., Zong, X., Truong, B., Zhao, S., Uddin, M. M., Niroula, A., Miller, C. A., Mukherjee, S., Heiden, B. T., Luo, J., Puri, V., Kozower, B. D., Walter, M. J., Ding, L., Link, D. C., Amos, C. I., Ebert, B. L., Govindan, R., & 3 others, Mar 1 2023, In: Journal of Clinical Oncology. 41, 7, p. 1423-1433 11 p.Research output: Contribution to journal › Article › peer-review
-
Trends in Stage I Lung Cancer
Singareddy, A., Flanagan, M. E., Samson, P. P., Waqar, S. N., Devarakonda, S., Ward, J., Herzog, B. H., Rohatgi, A., Robinson, C., Gao, F., Govindan, R., Puri, V. & Morgensztern, D., Mar 2023, In: Clinical Lung Cancer. 24, 2, p. 114-119 6 p.Research output: Contribution to journal › Article › peer-review
-
A Phase i Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients with Solid Tumor Malignancies
Fracasso, P. M., Goodner, S. A., Wildi, J. D., Naughton, M. J., Linette, G. P., Govindan, R., Tan, B. R., Blum, K. A., Jones, G. J., Pearce, T. E., Levitt, D. J. & Clamon, G. H., Jul 1 2022, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 45, 7, p. 294-297 4 p.Research output: Contribution to journal › Article › peer-review
-
Author Correction: Pathway and network analysis of more than 2500 whole cancer genomes (Nature Communications, (2020), 11, 1, (729), 10.1038/s41467-020-14367-0)
PCAWG Drivers and Functional Interpretation Working Group & PCAWG Consortium, Dec 1 2022, In: Nature communications. 13, 1, 7566.Research output: Contribution to journal › Comment/debate
Open Access